Abstract

*Ayesha Shayan, Yussra Khattri, Rida Zainab, Saman Anwar, Rabia Ahmed and Misbah Tahir

ABSTRACT

Hepatocellular carcinoma is the 4th most common cancer in the World. Ruptured hepatocellular carcinoma (HCC) is indeed a serious and life-threatening complication. It is a relatively rare occurrence, happening in 3 to 15% of HCC cases, but it can lead to significant hemorrhage and a high mortality rate, with up to 75% of affected patients not surviving. Abdominal pain is the predominant symptom of ruptured hepatocellular carcinoma (HCC). To diagnose and confirm the condition, contrast-enhanced MDCT, an advanced imaging technique that provides detailed liver images, is done. This enables healthcare professionals to identify the rupture and evaluate its extent and severity. The available treatment choices for ruptured hepatocellular carcinoma consist of surgical resection, placation or packing, hepatic artery ligation, and transcatheter arterial embolization (TAE). The selection of the appropriate treatment depends on various factors, such as the patient's overall health, the extent of tumor involvement, the availability of treatment resources, and the expertise of the medical team. At our institution, we had a new experience when we came across an elderly male patient with a ruptured hepatocellular carcinoma (HCC). It was the first instance of encountering such a case in our setup.